Post-transcriptional control of HIF-1α by MBNL1 restrains hypoxia-driven stemness in GBM

MBNL1 binds the HIF-1α 3'UTR to promote rapid mRNA decay, thereby limiting HIF-1 activity and hypoxia-induced stemness in glioblastoma. Using patient-derived glioma stem cells, we show that MBNL1 loss stabilizes HIF-1α mRNA and increases HIF-1α protein, HRE reporter activity, and target gene expression under hypoxia; MBNL1 knockout also prolongs target gene expression after reoxygenation, indicating enhanced hypoxia "memory." MBNL1 depletion markedly elevates stemness markers (KLF4, SOX2, GLI1) and clonogenic growth, and re-expression of MBNL1 reverses these effects. These results identify a post-transcriptional MBNL1-HIF1α axis that controls hypoxia signaling and stemness, with implications for GBM therapy.

Authors

Institutions

Publication Details

Journal
Neoplasia
Published
2025-12-08
DOI
https://doi.org/10.1016/j.neo.2025.101262
Primary Topic
Cancer, Hypoxia, and Metabolism
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Post-transcriptional control of HIF-1α by MBNL1 restrains hypoxia-driven stemness in GBM

Gerald M. Wilson, Eli E. Bar, Ian Mills, L. Åkerman et al.
Neoplasia
Cancer, Hypoxia, and Metabolism
article

Post-transcriptional control of HIF-1α by MBNL1 restrains hypoxia-driven stemness in GBM

Gerald M. Wilson, Eli E. Bar, Ian Mills, L. Åkerman, Chixiang Chen, Jeffrey A. Winkles, Xiaoxuan Fan, Haoyu Ren, Fahim Ahmad, Nina C. Lee, Graeme F. Woodworth, Blair P. Rendina
article en

Abstract

MBNL1 binds the HIF-1α 3'UTR to promote rapid mRNA decay, thereby limiting HIF-1 activity and hypoxia-induced stemness in glioblastoma. Using patient-derived glioma stem cells, we show that MBNL1 loss stabilizes HIF-1α mRNA and increases HIF-1α protein, HRE reporter activity, and target gene expression under hypoxia; MBNL1 knockout also prolongs target gene expression after reoxygenation, indicating enhanced hypoxia "memory." MBNL1 depletion markedly elevates stemness markers (KLF4, SOX2, GLI1) and clonogenic growth, and re-expression of MBNL1 reverses these effects. These results identify a post-transcriptional MBNL1-HIF1α axis that controls hypoxia signaling and stemness, with implications for GBM therapy.

NeoplasiaVol. 72
University of Maryland, Baltimore (US), University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore County (US)
Openalex Percentile: Top 52%
Cancer, Hypoxia, and Metabolism
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.